Credit and interest ratesmixed · 3 filings
“In 2024, cash usage was largely attributable to a $30.0 million repayment under the Revolving Credit Facility, which represented the majority of the financing activities for the year.”10-K · Feb 25, 2026 ↗
MiMedx Group, Inc.
MDXG
Market read
MiMedx Group, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 32 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.
Company-2.3% todayVolume comparison unavailable
Market group0 of 32 activeRegional Banks · unavailable
Disclosed network0 of 4 confirmingNo filing-linked name is confirming now
What would change this read
Watch this read- MDXG's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if MDXG's group or a disclosed connection begins moving with it.
Research brief
The story so far
No new filing conclusion is available. 0 of 32 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.
Evidence that supports
No thresholded supportive filing evidence is available yet.
Evidence that challenges
No thresholded adverse filing evidence is available yet.
What would clarify the read
- MDXG's market-adjusted activity becomes unusual and at least one connected name confirms.
Company research
Understand the business, not just the ticker
Business model and earnings drivers
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
Key research questions
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
Annual periods9
Price observations319
Usable filing statements73
Verified relationships4
Evidence supporting the case
- Latest annual revenue changed +20.0% year over year.
Evidence challenging the case
- Operating margin changed -1.6 percentage points in the latest annual period.
Questions before a position
- P/E is 88% below the available filing-peer median; determine whether growth and quality justify the difference.
- EV/sales is 81% below the available filing-peer median; determine whether growth and quality justify the difference.
Longer-term price context
Price as of Sep 10, 2026
4.616m-5.8%12m-35.8%24m—
Annual trajectory
Reported annual revenue and per-share history. This is accounting history, not a forecast.
PeriodRevenueYoYDiluted EPSShare change
2021-12-31$242.0M-2.5%$-0.15+1.9%
2022-12-31$267.8M+10.7%$-0.33+2.3%
2023-12-31$321.5M+20.0%$0.37+29.3%
2024-12-31$348.9M+8.5%$0.28+2.1%
2025-12-31$418.6M+20.0%$0.32+0.5%
What management says matters
Persistent and emerging business drivers
Legal and regulatory exposurepositive · 3 filings
“General and administrative expense increased $7.0 million, or 14.1%, year-over-year, driven by ongoing legal and regulatory disputes, transaction-related costs, and severance costs.”10-K · Feb 25, 2026 ↗
Input and raw-material costsnegative · 2 filings
“This decline was primarily driven by lower Wound Care pricing following the Medicare reimbursement changes, as well as unfavorable product mix and higher costs.”10-Q · Apr 29, 2026 ↗
Product pipeline and R&Dmixed · 2 filings
“OB3 resulted in a current tax benefit resulting from the utilization of deferred tax assets, primarily relating to the utilization of capitalized research and development expenses, and did not affect our effective tax rate in the year ended December 31, 2025.”10-K · Feb 25, 2026 ↗
Valuation discipline
Descriptive valuation snapshot
Price/sales 1.6× · EV/sales 1.3×. Comparisons use only industry-matched filing peers.
Scenario scaffold
Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.
Price action
How the market is pricing the story
4.56-2.3% today
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 15:05 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for MDXG. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Filing analysis
No comparable filing assessment is available yet
Jodie has not yet found a suitable current-versus-prior filing comparison for MDXG. This does not mean the latest filing was neutral or immaterial.
Business ecosystem
The relationships behind MDXG
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
WMWaste Management, Inc.supplierFeb 25, 2026 ▾
“The review looked at several areas including: • Air Pollution Control Management • Battery Handling and Disposal • Community Right-to-Know (Hazardous Material Reporting) • Hazardous Waste Management • SARA Title III (Release Reporting) • Solid Waste Managemen…”
IARTIntegra LifeSciences Holdings CorporationcompetitorFeb 25, 2026 ▾
“Our main publicly-traded competitors in the skin substitute market include Integra LifeSciences Holdings Corporation, Organogenesis, Inc., and Smith & Nephew plc, which sell a variety of AWC products, including skin substitutes and placental tissue allografts.”
ORGOFiling-linked namecompetitorFeb 25, 2026 ▾
“Our main publicly-traded competitors in the skin substitute market include Integra LifeSciences Holdings Corporation, Organogenesis, Inc., and Smith & Nephew plc, which sell a variety of AWC products, including skin substitutes and placental tissue allografts.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 2 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
MDXG is currently a Follower in the organic co-movement group Regional Banks. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for MDXG; it is not active in the latest market snapshot.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.